An outbreak of Phialemonium infective endocarditis linked to intracavernous penile injections for the treatment of impotence

Clinical Infectious Diseases

Volumn 40, Issue 6, 2005, Pages 781-786

  Strahilevitz, Jacob ^a,f   Rahav, Galia ^a   Schroers, Hans Josef ^d   Summerbell, Richard C ^d   Amitai, Ziva ^b   Goldschmied Reouven, Anna ^a   Rubinstein, Ethan ^a   Schwammenthal, Yvonne ^a   Feinberg, Micha S ^a   Siegman Igra, Yardena ^a   Bash, Edna ^a   Polacheck, Itzhack ^c   Zelazny, Adrian ^a   Howard, Susan J ^e   Cibotaro, Pnina ^a   Shovman, Ora ^a   Keller, Nathan ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b MINISTRY OF HEALTH   (Israel)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^d CBS KNAW FUNGAL BIODIVERSITY CENTRE   (Netherlands)

^e HOPE HOSPITAL   (United Kingdom)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERNAL TRANSCRIBED SPACER;

ADULT; AGED; ARTICLE; CASE REPORT; DNA SEQUENCE; ENDOCARDITIS; GENOTYPE; HUMAN; IMPOTENCE; INFECTION; MALE; MOULD; NUCLEOTIDE SEQUENCE; PAECILOMYCES LILACINUS; PATHOGENICITY; PHIALEMONIUM CURVATUM; PRIORITY JOURNAL; SYRINGE;

AGED; AGED, 80 AND OVER; ASCOMYCOTA; DISEASE OUTBREAKS; ENDOCARDITIS; EQUIPMENT REUSE; HUMANS; IMPOTENCE; ISRAEL; MALE; MYCOSES;

EID: 20144367330     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/428045     Document Type: Article

References (26)

1. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151:54-61.
2. Shabsigh R, Padma-Nathan H, Gittleman M, McMurray J, Kaufman J, Goldstein I. Intracavernous alprostadil alphadex (Edex/Viridal) is effective and safe in patients with erectile dysfunction after failing sildenafil (Viagra). Urology 2000; 55:477-80.
3. Gavin PJ, Sutton DA, Katz BZ. Fatal endocarditis in a neonate caused by the dematiaceous fungus Phialemonium obovatum: case report and review of the literature. J Clin Microbiol 2002; 40:2207-2212.
4. de Hoog GS, Guarro J, Gené J, Figueras MJ. Atlas of clinical fungi. 2nd ed. Utrecht, The Netherlands: Centraalbureau voor Schimmelcultures, 2000.
5. NCCLS. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard. Document M38-A. Wayne, PA: NCCLS, 2002.
6. Keevil BG, Newman S, Lockhart S, Moore CB, Howard SJ, Denning DW. Validation of an assay for voriconazole in serum samples using liquid chromatography-tandem mass spectrometry. Ther Drug Monit 2004; 26:650-7.
7. Proia LA, Hayden MK, Kammeyer PL, et al. Phialemonium, an emerging mold pathogen causing 4 cases of hemodialysis-associated endovascular infection. Clin Infect Dis 2004; 39:373-9.
8. Kapoor VK, Chahal AS, Jyoti SP, Mundkur YJ, Kotwal SV, Mehta VK. Intracavernous papaverine for impotence in spinal cord injured patients. Paraplegia 1993; 31:675-7.
9. Lakin MM, Montague DK, VanderBrug Medendorp S, Tesar L, Schover LR. Intracavernous injection therapy: analysis of results and complications. J Urol 1990; 143:1138-41.
10. Girdley FM, Bruskewitz RC, Feyzi J, Graversen PH, Gasser TC. Intracavernous self-injection for impotence: a long-term therapeutic option? Experience in 78 patients. J Urol 1988; 140:972-4.
11. Schwarzer JU, Hofmann R, Leyh H. Purulent cavernitis as a complication of self injection into the cavernous body [in German]. Urologe A 1991; 30:70-1.
12. Parfitt VJ, Wong R, Dobbie A, Hartog M, Gingell JC. Staphylococcal septicaemia complicating intracavernosal autoinjection therapy for impotence in a man with diabetes. Diabet Med 1992; 9:947-9.
13. Murphy EL, DeVita D, Liu H, et al. Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study. Clin Infect Dis 2001; 33:35-40.
14. Ellis ME, Al-Abdely H, Sandridge A, Greer W, Ventura W. Fungal endocarditis: evidence in the world literature, 1965-1995. Clin Infect Dis 2001; 32:50-62.
15. Pierrotti LC, Baddour LM. Fungal endocarditis, 1995-2000. Chest 2002; 122:302-10.
16. Guarro J, Nucci M, Akiti T, et al. Phialemonium fungemia: two documented nosocomial cases. J Clin Microbiol 1999; 37:2493-7.
17. Schonheyder HC, Jensen HE, Gams W, et al. Late bioprosthetic valve endocarditis caused by Phialemonium aff. curvatum and Streptococcus sanguis: a case report. J Med Vet Mycol 1996; 34:209-14.
18. Rubinstein E, Noriega ER, Simberkoff MS, Holzman R, Rahal JJ Jr. Fungal endocarditis: analysis of 24 cases and review of the literature. Medicine (Baltimore) 1975; 54:331-4.
19. Gumbo T, Taege AJ, Mawhorter S, et al. Aspergillus valve endocarditis in patients without prior cardiac surgery. Medicine (Baltimore) 2000; 79:261-8.
20. Revankar SG, Patterson JE, Sutton DA, Pullen R, Rinaldi MG. Disseminated phaeohyphomycosis: review of an emerging mycosis. Clin Infect Dis 2002; 34:467-76.
21. Camin AM, Michelet C, Langanay T, et al. Endocarditis due to Fusarium dimerum four years after coronary artery bypass grafting. Clin Infect Dis 1999; 28:150.
22. Khan ZU, Sanyal SC, Mokaddas E, et al. Endocarditis due to Aspergillus flavus. Mycoses 1997; 40:213-7.
23. Roux JP, Koussa A, Cajot MA, et al. Primary Aspergillus endocarditis: apropos of a case and review of the international literature [in French]. Ann Chir 1992; 46:110-5.
24. Centers for Disease Control and Prevention. Exophiala infection from contaminated injectable steroids prepared by a compounding pharmacy - United States, July-November 2002. MMWR Morb Mortal Wkly Rep 2002; 51:1109-12.
25. Selenic D, Dodson DR, Jensen B, Arduino MJ, Panlilio A, Archibald LK. Enterobacter cloacae bloodstream infections in pediatric patients traced to a hospital pharmacy. Am J Health Syst Pharm 2003; 60:1440-6.
26. Chun J, Carson CC 3rd. Physician-patient dialogue and clinical evaluation of erectile dysfunction. Urol Clin North Am 2001; 28:249-58.